{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:56:09Z","timestamp":1786985769550,"version":"build-2736575974"},"reference-count":81,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004543","name":"China Scholarship Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004543","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemico-Biological Interactions"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.cbi.2022.110062","type":"journal-article","created":{"date-parts":[[2022,7,30]],"date-time":"2022-07-30T20:16:30Z","timestamp":1659212190000},"page":"110062","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Artemisinin derivative FO-ARS-123 as a novel VEGFR2 inhibitor suppresses angiogenesis, cell migration, and invasion"],"prefix":"10.1016","volume":"365","author":[{"given":"Xiaohua","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Elbadawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Blatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed E.M.","family":"Saeed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolin","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edmond","family":"Fleischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peer W.","family":"K\u00e4mmerer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Efferth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6626","key":"10.1016\/j.cbi.2022.110062_bib1","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/386671a0","article-title":"Mechanisms of angiogenesis","volume":"386","author":"Risau","year":"1997","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.cbi.2022.110062_bib2","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/labinvest.3780252","article-title":"In vitro models of vasculogenesis and angiogenesis","volume":"81","author":"Vailh\u00e9","year":"2001","journal-title":"Lab. Invest."},{"issue":"21","key":"10.1016\/j.cbi.2022.110062_bib3","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1056\/NEJM197111182852108","article-title":"Tumor angiogenesis: therapeutic implications","volume":"285","author":"Folkman","year":"1971","journal-title":"N. Engl. J. Med."},{"issue":"Suppl 3","key":"10.1016\/j.cbi.2022.110062_bib4","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1159\/000088479","article-title":"VEGF as a therapeutic target in cancer","volume":"69","author":"Ferrara","year":"2005","journal-title":"Oncology"},{"issue":"8","key":"10.1016\/j.cbi.2022.110062_bib5","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/nrc2403","article-title":"VEGF-targeted therapy: mechanisms of anti-tumour activity","volume":"8","author":"Ellis","year":"2008","journal-title":"Nat. Rev. Cancer"},{"issue":"17","key":"10.1016\/j.cbi.2022.110062_bib6","doi-asserted-by":"crossref","first-page":"5018","DOI":"10.1158\/1078-0432.CCR-06-1520","article-title":"Vascular endothelial growth factor signaling pathways: therapeutic perspective","volume":"12","author":"Kowanetz","year":"2006","journal-title":"Clin. Cancer Res."},{"issue":"10","key":"10.1016\/j.cbi.2022.110062_bib7","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/nrm.2016.87","article-title":"Mechanisms and regulation of endothelial VEGF receptor signalling","volume":"17","author":"Simons","year":"2016","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"3","key":"10.1016\/j.cbi.2022.110062_bib8","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1023\/B:BREA.0000004357.92232.cb","article-title":"Tumor specific VEGF-A and VEGFR2\/KDR protein are co-expressed in breast cancer","volume":"82","author":"Ryd\u00e9n","year":"2003","journal-title":"Breast Cancer Res. Treat."},{"issue":"1","key":"10.1016\/j.cbi.2022.110062_bib9","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1756-9966-32-16","article-title":"Expression and prognostic value of VEGFR-2, PDGFR-\u03b2, and c-Met in advanced hepatocellular carcinoma","volume":"32","author":"Chu","year":"2013","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"4","key":"10.1016\/j.cbi.2022.110062_bib10","first-page":"1269","article-title":"VEGFR1 and VEGFR2 immunohistochemical expression in oral squamous cell carcinoma: a morphometric study, Rom","volume":"52","author":"St\u00eeng\u0103","year":"2011","journal-title":"J. Morphol. Embryol."},{"issue":"8","key":"10.1016\/j.cbi.2022.110062_bib11","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1158\/0008-5472.CAN-11-3406","article-title":"Anti-VEGF\/VEGFR therapy for cancer: reassessing the target","volume":"72","author":"Sitohy","year":"2012","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.cbi.2022.110062_bib12","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1007\/s11033-020-05306-9","article-title":"Targeting signaling pathways of VEGFR1 and VEGFR2 as a potential target in the treatment of breast cancer","volume":"47","author":"Farzaneh Behelgardi","year":"2020","journal-title":"Mol. Biol. Rep."},{"issue":"11","key":"10.1016\/j.cbi.2022.110062_bib13","doi-asserted-by":"crossref","DOI":"10.1038\/nrc3390","article-title":"A deeper understanding of VEGFR inhibitors","volume":"12","author":"Harrison","year":"2012","journal-title":"Nat. Rev. Cancer"},{"issue":"2","key":"10.1016\/j.cbi.2022.110062_bib14","doi-asserted-by":"crossref","first-page":"132","DOI":"10.2174\/157488408784293705","article-title":"The molecular basis of class side effects due to treatment with inhibitors of the VEGF\/VEGFR pathway","volume":"3","author":"Roodhart","year":"2008","journal-title":"Curr. Clin. Pharmacol."},{"issue":"21","key":"10.1016\/j.cbi.2022.110062_bib15","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13215536","article-title":"Management of VEGFR-targeted TKI for thyroid cancer","volume":"13","author":"Enokida","year":"2021","journal-title":"Cancers"},{"issue":"4","key":"10.1016\/j.cbi.2022.110062_bib16","first-page":"767","article-title":"The anti-malarial artesunate is also active against cancer","volume":"18","author":"Efferth","year":"2001","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.cbi.2022.110062_bib17","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.semcancer.2017.02.009","article-title":"From ancient herb to modern drug: Artemisia annua and artemisinin for cancer therapy","volume":"46","author":"Efferth","year":"2017","journal-title":"Semin. Cancer Biol."},{"issue":"5","key":"10.1016\/j.cbi.2022.110062_bib18","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1111\/j.1582-4934.2010.01120.x","article-title":"Design of novel artemisinin-like derivatives with cytotoxic and anti-angiogenic properties","volume":"15","author":"Soomro","year":"2011","journal-title":"J. Cell Mol. Med."},{"issue":"6","key":"10.1016\/j.cbi.2022.110062_bib19","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1016\/j.biotechadv.2018.01.001","article-title":"Beyond malaria: the inhibition of viruses by artemisinin-type compounds","volume":"36","author":"Efferth","year":"2018","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.cbi.2022.110062_bib20","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.canlet.2018.05.008","article-title":"Prevention of carcinogenesis and metastasis by artemisinin-type drugs","volume":"429","author":"Abba","year":"2018","journal-title":"Cancer Lett."},{"issue":"2","key":"10.1016\/j.cbi.2022.110062_bib21","doi-asserted-by":"crossref","first-page":"329","DOI":"10.2174\/0929867327666200121124404","article-title":"Ferroptosis: a novel mechanism of artemisinin and its derivatives in cancer therapy","volume":"28","author":"Zhu","year":"2021","journal-title":"Curr. Med. Chem."},{"issue":"1","key":"10.1016\/j.cbi.2022.110062_bib22","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ebiom.2014.11.010","article-title":"A randomised, double blind, placebo-controlled pilot study of oral artesunate therapy for colorectal cancer","volume":"2","author":"Krishna","year":"2015","journal-title":"EBioMedicine"},{"issue":"2","key":"10.1016\/j.cbi.2022.110062_bib23","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s10549-017-4261-1","article-title":"Prospective open uncontrolled phase I study to define a well-tolerated dose of oral artesunate as add-on therapy in patients with metastatic breast cancer (ARTIC M33\/2)","volume":"164","author":"von Hagens","year":"2017","journal-title":"Breast Cancer Res. Treat."},{"issue":"3","key":"10.1016\/j.cbi.2022.110062_bib24","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s00280-018-3533-8","article-title":"A phase I study of intravenous artesunate in patients with advanced solid tumor malignancies","volume":"81","author":"Deeken","year":"2018","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"12","key":"10.1016\/j.cbi.2022.110062_bib25","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.3390\/cells9122643","article-title":"Artesunate impairs growth in cisplatin-resistant bladder cancer cells by cell cycle arrest, apoptosis and autophagy induction","volume":"9","author":"Zhao","year":"2020","journal-title":"Cells"},{"issue":"4","key":"10.1016\/j.cbi.2022.110062_bib26","first-page":"1929","article-title":"Quantitative structure-activity relationship and molecular docking of artemisinin derivatives to vascular endothelial growth factor receptor 1","volume":"35","author":"Saeed","year":"2015","journal-title":"Anticancer Res."},{"key":"10.1016\/j.cbi.2022.110062_bib27","article-title":"Antiangiogenic activity and pharmacogenomics of medicinal plants from traditional Korean medicine","author":"Seo","year":"2013","journal-title":"Evid. base Compl. Alternative Mach. 2013"},{"issue":"12","key":"10.1016\/j.cbi.2022.110062_bib28","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1016\/j.phymed.2014.07.011","article-title":"Cytotoxicity of the bisphenolic honokiol from Magnolia officinalis against multiple drug-resistant tumor cells as determined by pharmacogenomics and molecular docking","volume":"21","author":"Saeed","year":"2014","journal-title":"Phytomedicine"},{"key":"10.1016\/j.cbi.2022.110062_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105076","article-title":"Inhibition of cell migration and induction of apoptosis by a novel class II histone deacetylase inhibitor, MCC2344","volume":"160","author":"Dawood","year":"2020","journal-title":"Pharmacol. Res."},{"issue":"7","key":"10.1016\/j.cbi.2022.110062_bib30","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.3390\/biom10071000","article-title":"Chemopreventive property of Sencha tea extracts towards sensitive and multidrug-resistant leukemia and multiple myeloma cells","volume":"10","author":"Lu","year":"2020","journal-title":"Biomolecules"},{"issue":"2","key":"10.1016\/j.cbi.2022.110062_bib31","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.phymed.2015.01.002","article-title":"Cytotoxicity of the indole alkaloid reserpine from Rauwolfia serpentina against drug-resistant tumor cells","volume":"22","author":"Abdelfatah","year":"2015","journal-title":"Phytomedicine"},{"key":"10.1016\/j.cbi.2022.110062_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114677","article-title":"A novel moniliformin derivative as pan-inhibitor of histone deacetylases triggering apoptosis of leukemia cells","volume":"194","author":"Lu","year":"2021","journal-title":"Biochem. Pharmacol."},{"issue":"10","key":"10.1016\/j.cbi.2022.110062_bib33","doi-asserted-by":"crossref","first-page":"3180","DOI":"10.1016\/j.biomaterials.2013.12.059","article-title":"Human endothelial cell-based assay for endotoxin as sensitive as the conventional Limulus amebocyte lysate assay","volume":"35","author":"Unger","year":"2014","journal-title":"Biomaterials"},{"issue":"2","key":"10.1016\/j.cbi.2022.110062_bib34","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1016\/j.jid.2016.11.020","article-title":"Research techniques made simple: analysis of collective cell migration using the wound healing assay","volume":"137","author":"Grada","year":"2017","journal-title":"J. Invest. Dermatol."},{"issue":"7","key":"10.1016\/j.cbi.2022.110062_bib35","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1021\/ja068008h","article-title":"Fluorescent biomembrane probe for ratiometric detection of apoptosis","volume":"129","author":"Shynkar","year":"2007","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.cbi.2022.110062_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114788","article-title":"Cytotoxicity of 4-hydroxy-N-(naphthalen-1-yl)-2-oxo-2H-chromene-3-carboxamide in multidrug-resistant cancer cells through activation of PERK\/eIF2\u03b1\/ATF4 pathway","volume":"193","author":"Lu","year":"2021","journal-title":"Biochem. Pharmacol."},{"issue":"1","key":"10.1016\/j.cbi.2022.110062_bib37","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3390\/biomedicines9010061","article-title":"Does platelet-rich fibrin enhance the early angiogenetic potential of different bone substitute materials? An in vitro and in vivo analysis","volume":"9","author":"Blatt","year":"2021","journal-title":"Biomedicines"},{"issue":"3","key":"10.1016\/j.cbi.2022.110062_bib38","doi-asserted-by":"crossref","first-page":"706","DOI":"10.3390\/biomedicines10030706","article-title":"Biofunctionalization of xenogeneic collagen membranes with autologous platelet concentrate-influence on rehydration protocol and angiogenesis","volume":"10","author":"Blatt","year":"2022","journal-title":"Biomedicines"},{"issue":"2","key":"10.1016\/j.cbi.2022.110062_bib39","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1593\/neo.07112","article-title":"Oncomine 3.0: genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles","volume":"9","author":"Rhodes","year":"2007","journal-title":"Neoplasia"},{"issue":"1","key":"10.1016\/j.cbi.2022.110062_bib40","first-page":"18","article-title":"PrognoScan: a new database for meta-analysis of the prognostic value of genes","volume":"2","author":"Mizuno","year":"2009","journal-title":"BMC Med. Genet."},{"issue":"1","key":"10.1016\/j.cbi.2022.110062_bib41","doi-asserted-by":"crossref","first-page":"9227","DOI":"10.1038\/s41598-018-27521-y","article-title":"Validation of miRNA prognostic power in hepatocellular carcinoma using expression data of independent datasets","volume":"8","author":"Nagy","year":"2018","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.cbi.2022.110062_bib42","doi-asserted-by":"crossref","first-page":"501","DOI":"10.2174\/1389450119666181022153016","article-title":"Molecular docking: challenges, advances and its use in drug discovery perspective","volume":"20","author":"Surovi","year":"2019","journal-title":"Curr. Drug Targets"},{"issue":"17","key":"10.1016\/j.cbi.2022.110062_bib43","doi-asserted-by":"crossref","first-page":"5452","DOI":"10.1016\/j.bmc.2015.07.048","article-title":"Highly potent artemisinin-derived dimers and trimers: synthesis and evaluation of their antimalarial, antileukemia and antiviral activities","volume":"23","author":"Reiter","year":"2015","journal-title":"Bioorg. Med. Chem."},{"issue":"1","key":"10.1016\/j.cbi.2022.110062_bib44","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1021\/jm201214d","article-title":"Malaria-infected mice are completely cured by one 6 mg\/kg oral dose of a new monomeric trioxane sulfide combined with mefloquine","volume":"55","author":"Slack","year":"2012","journal-title":"J. Med. Chem."},{"issue":"8","key":"10.1016\/j.cbi.2022.110062_bib45","doi-asserted-by":"crossref","first-page":"2991","DOI":"10.1128\/AAC.00225-07","article-title":"Peroxide bond-dependent antiplasmodial specificity of artemisinin and OZ277 (RBx11160)","volume":"51","author":"Kaiser","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"issue":"11","key":"10.1016\/j.cbi.2022.110062_bib46","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1016\/j.bmcl.2014.04.025","article-title":"Antimalarial chemotherapy: artemisinin-derived dimer carbonates and thiocarbonates","volume":"24","author":"Mazzone","year":"2014","journal-title":"Bioorg. Med. Chem. Lett"},{"issue":"3","key":"10.1016\/j.cbi.2022.110062_bib47","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0009582","article-title":"Artemisinin directly targets malarial mitochondria through its specific mitochondrial activation","volume":"5","author":"Wang","year":"2010","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.cbi.2022.110062_bib48","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s13659-017-0142-x","article-title":"Computational analysis of artimisinin derivatives on the antitumor activities","volume":"7","author":"Liu","year":"2017","journal-title":"Nat. Prod. Bioprospect."},{"issue":"4","key":"10.1016\/j.cbi.2022.110062_bib49","doi-asserted-by":"crossref","first-page":"841","DOI":"10.3390\/molecules23040841","article-title":"Treatment of multidrug-resistant leukemia cells by novel artemisinin-, egonol-, and thymoquinone-derived hybrid compounds","volume":"23","author":"Gruber","year":"2018","journal-title":"Molecules"},{"issue":"6","key":"10.1016\/j.cbi.2022.110062_bib50","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.1021\/jm400058j","article-title":"Synthesis and antimalarial efficacy of two-carbon-linked, artemisinin-derived trioxane dimers in combination with known antimalarial drugs","volume":"56","author":"Mott","year":"2013","journal-title":"J. Med. Chem."},{"issue":"11","key":"10.1016\/j.cbi.2022.110062_bib51","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.3390\/molecules22111881","article-title":"Peroxides with anthelmintic, antiprotozoal, fungicidal and antiviral bioactivity: properties, synthesis and reactions","volume":"22","author":"Vil\u2019","year":"2017","journal-title":"Molecules"},{"issue":"5","key":"10.1016\/j.cbi.2022.110062_bib52","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/j.bmcl.2014.01.059","article-title":"The survival times of malaria-infected mice are prolonged more by several new two-carbon-linked artemisinin-derived dimer carbamates than by the trioxane antimalarial drug artemether","volume":"24","author":"Conyers","year":"2014","journal-title":"Bioorg. Med. Chem. Lett"},{"issue":"17","key":"10.1016\/j.cbi.2022.110062_bib53","doi-asserted-by":"crossref","first-page":"7892","DOI":"10.1021\/jm3009986","article-title":"Malaria-infected mice live until at least day 30 after a new artemisinin-derived thioacetal thiocarbonate combined with mefloquine are administered together in a single, low, oral dose","volume":"55","author":"Jacobine","year":"2012","journal-title":"J. Med. Chem."},{"issue":"23","key":"10.1016\/j.cbi.2022.110062_bib54","doi-asserted-by":"crossref","first-page":"7949","DOI":"10.1016\/j.bmc.2009.10.019","article-title":"Antiprotozoal, anticancer and antimicrobial activities of dihydroartemisinin acetal dimers and monomers","volume":"17","author":"Slade","year":"2009","journal-title":"Bioorg. Med. Chem."},{"issue":"3","key":"10.1016\/j.cbi.2022.110062_bib55","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.bcp.2008.10.015","article-title":"Accumulation of artemisinin trioxane derivatives within neutral lipids of Plasmodium falciparum malaria parasites is endoperoxide-dependent","volume":"77","author":"Hartwig","year":"2009","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.cbi.2022.110062_bib56","series-title":"Angiogenesis Protocols","first-page":"183","article-title":"Tube formation: an in vitro matrigel angiogenesis assay","author":"Ponce","year":"2009"},{"issue":"12","key":"10.1016\/j.cbi.2022.110062_bib57","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1038\/ncb3443","article-title":"Asymmetric division coordinates collective cell migration in angiogenesis","volume":"18","author":"Costa","year":"2016","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.cbi.2022.110062_bib58","first-page":"27","article-title":"The production of 3D tumor spheroids for cancer drug discovery, Drug Discov","volume":"23","author":"Sant","year":"2017","journal-title":"Today Technol."},{"issue":"5","key":"10.1016\/j.cbi.2022.110062_bib59","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/nrc1075","article-title":"Tumour-cell invasion and migration: diversity and escape mechanisms","volume":"3","author":"Friedl","year":"2003","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.cbi.2022.110062_bib60","first-page":"181","article-title":"Chapter 5 chick embryo chorioallantoic membrane as a useful tool to study angiogenesis","author":"Ribatti","year":"2008","journal-title":"Int. Rev. Cell. Mol. Biol"},{"issue":"2","key":"10.1016\/j.cbi.2022.110062_bib61","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.str.2016.12.012","article-title":"Structure of the full-length VEGFR-1 extracellular domain in complex with VEGF-A","volume":"25","author":"Markovic-Mueller","year":"2017","journal-title":"Structure"},{"key":"10.1016\/j.cbi.2022.110062_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.medidd.2019.100009","article-title":"Vascular endothelial growth factor receptor (VEGFR-2)\/KDR inhibitors: medicinal chemistry perspective","volume":"2","author":"Modi","year":"2019","journal-title":"Med. Drug Discov."},{"issue":"11","key":"10.1016\/j.cbi.2022.110062_bib63","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1080\/13543776.2021.1935872","article-title":"An updated patent review of VEGFR-2 inhibitors (2017-present)","volume":"31","author":"Farghaly","year":"2021","journal-title":"Expert Opin. Ther. Pat."},{"issue":"3","key":"10.1016\/j.cbi.2022.110062_bib64","doi-asserted-by":"crossref","first-page":"277","DOI":"10.2174\/1573406414666180912113226","article-title":"ZnO Nanoparticles catalyst in the synthesis of bioactive fused pyrimidines as anti-breast cancer agents targeting VEGFR-2","volume":"15","author":"Dawood","year":"2019","journal-title":"Med. Chem."},{"issue":"12","key":"10.1016\/j.cbi.2022.110062_bib65","first-page":"123","article-title":"Clinical advances in the development of novel VEGFR2 inhibitors","volume":"2","author":"Fontanella","year":"2014","journal-title":"Ann. Transl. Med."},{"issue":"4","key":"10.1016\/j.cbi.2022.110062_bib66","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s12185-010-0697-3","article-title":"Artesunate inhibiting angiogenesis induced by human myeloma RPMI8226 cells","volume":"92","author":"Chen","year":"2010","journal-title":"Int. J. Hematol."},{"issue":"5","key":"10.1016\/j.cbi.2022.110062_bib67","doi-asserted-by":"crossref","first-page":"3400","DOI":"10.1167\/iovs.12-11068","article-title":"The artemisinin derivative artesunate inhibits corneal neovascularization by inducing ROS-dependent apoptosis in vascular endothelial cells","volume":"54","author":"Cheng","year":"2013","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"issue":"1","key":"10.1016\/j.cbi.2022.110062_bib68","first-page":"108","article-title":"Vascular endothelial growth factor receptor-2 in breast cancer","volume":"1806","author":"Guo","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"issue":"4","key":"10.1016\/j.cbi.2022.110062_bib69","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1136\/jcp.2010.085142","article-title":"Prognostic significance and potential therapeutic target of VEGFR2 in hepatocellular carcinoma","volume":"64","author":"Huang","year":"2011","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.cbi.2022.110062_bib70","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.yexmp.2019.01.006","article-title":"The anti-malarial drug artesunate causes cell cycle arrest and apoptosis of triple-negative MDA-MB-468 and HER2-enriched SK-BR-3 breast cancer cells","volume":"107","author":"Greenshields","year":"2019","journal-title":"Exp. Mol. Pathol."},{"issue":"3","key":"10.1016\/j.cbi.2022.110062_bib71","first-page":"691","article-title":"Artesunate induces ER-derived-ROS-mediated cell death by disrupting labile iron pool and iron redistribution in hepatocellular carcinoma cells","volume":"11","author":"Jiang","year":"2021","journal-title":"Am. J. Cancer Res."},{"issue":"3","key":"10.1016\/j.cbi.2022.110062_bib72","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S1043-6618(03)00107-5","article-title":"Inhibition of human cancer cell line growth and human umbilical vein endothelial cell angiogenesis by artemisinin derivatives in vitro","volume":"48","author":"Chen","year":"2003","journal-title":"Pharmacol. Res."},{"issue":"14","key":"10.1016\/j.cbi.2022.110062_bib73","doi-asserted-by":"crossref","first-page":"3783","DOI":"10.1016\/j.bmc.2004.05.013","article-title":"Synthesis and antiangiogenic activity of thioacetal artemisinin derivatives","volume":"12","author":"Oh","year":"2004","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.cbi.2022.110062_bib74","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellimm.2022.104500","article-title":"Artemisinin derivative TPN10466 suppresses immune cell migration and Th1\/Th17 differentiation to ameliorate disease severity in experimental autoimmune encephalomyelitis","volume":"373","author":"Liu","year":"2022","journal-title":"Cell. Immunol."},{"issue":"11","key":"10.1016\/j.cbi.2022.110062_bib75","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1093\/emboj\/20.11.2768","article-title":"A single autophosphorylation site on KDR\/Flk-1 is essential for VEGF-A-dependent activation of PLC-gamma and DNA synthesis in vascular endothelial cells","volume":"20","author":"Takahashi","year":"2001","journal-title":"EMBO J. gruber"},{"issue":"7","key":"10.1016\/j.cbi.2022.110062_bib76","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/s41419-020-02749-7","article-title":"Anlotinib suppresses tumor progression via blocking the VEGFR2\/PI3K\/AKT cascade in intrahepatic cholangiocarcinoma","volume":"11","author":"Song","year":"2020","journal-title":"Cell Death Dis."},{"issue":"8","key":"10.1016\/j.cbi.2022.110062_bib77","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1080\/07357907.2021.1954190","article-title":"Mechanisms and molecular targets of artemisinin in cancer treatment","volume":"39","author":"Li","year":"2021","journal-title":"Cancer Invest."},{"issue":"6","key":"10.1016\/j.cbi.2022.110062_bib78","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1002\/ijc.25315","article-title":"First evidence that the antimalarial drug artesunate inhibits invasion and in vivo metastasis in lung cancer by targeting essential extracellular proteases","volume":"127","author":"Rasheed","year":"2010","journal-title":"Int. J. Cancer"},{"issue":"5","key":"10.1016\/j.cbi.2022.110062_bib79","doi-asserted-by":"crossref","first-page":"405","DOI":"10.3109\/10408441003610571","article-title":"Toxicity of the antimalarial artemisinin and its dervatives","volume":"40","author":"Efferth","year":"2010","journal-title":"Crit. Rev. Toxicol."},{"issue":"7","key":"10.1016\/j.cbi.2022.110062_bib80","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1007\/s00204-021-03058-4","article-title":"Selection of safe artemisinin derivatives using a machine learning-based cardiotoxicity platform and in vitro and in vivo validation","volume":"95","author":"Kadioglu","year":"2021","journal-title":"Arch. Toxicol."},{"issue":"12","key":"10.1016\/j.cbi.2022.110062_bib81","first-page":"4417","article-title":"First study of oral Artenimol-R in advanced cervical cancer: clinical benefit, tolerability and tumor markers","volume":"31","author":"Jansen","year":"2011","journal-title":"Anticancer Res."}],"container-title":["Chemico-Biological Interactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279722002678?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279722002678?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T19:52:10Z","timestamp":1762113130000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009279722002678"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":81,"alternative-id":["S0009279722002678"],"URL":"https:\/\/doi.org\/10.1016\/j.cbi.2022.110062","relation":{},"ISSN":["0009-2797"],"issn-type":[{"value":"0009-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Artemisinin derivative FO-ARS-123 as a novel VEGFR2 inhibitor suppresses angiogenesis, cell migration, and invasion","name":"articletitle","label":"Article Title"},{"value":"Chemico-Biological Interactions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbi.2022.110062","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110062"}}